ZA200204420B - Amycomycin, a process for its production and its use as a pharmaceutical. - Google Patents

Amycomycin, a process for its production and its use as a pharmaceutical.

Info

Publication number
ZA200204420B
ZA200204420B ZA200204420A ZA200204420A ZA200204420B ZA 200204420 B ZA200204420 B ZA 200204420B ZA 200204420 A ZA200204420 A ZA 200204420A ZA 200204420 A ZA200204420 A ZA 200204420A ZA 200204420 B ZA200204420 B ZA 200204420B
Authority
ZA
South Africa
Prior art keywords
amycomycin
pharmaceutical
production
stereoisomeric
dsm
Prior art date
Application number
ZA200204420A
Other languages
English (en)
Inventor
Cordula Hopmann
Michael Kurz
Heinrich Decker
Dominique Le Beller
Jozsef Aszodi
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ZA200204420B publication Critical patent/ZA200204420B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200204420A 1999-12-08 2002-06-03 Amycomycin, a process for its production and its use as a pharmaceutical. ZA200204420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (1)

Publication Number Publication Date
ZA200204420B true ZA200204420B (en) 2003-09-03

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204420A ZA200204420B (en) 1999-12-08 2002-06-03 Amycomycin, a process for its production and its use as a pharmaceutical.

Country Status (28)

Country Link
US (1) US6642391B2 (zh)
EP (2) EP1106604A1 (zh)
JP (1) JP4750993B2 (zh)
KR (1) KR100728514B1 (zh)
CN (1) CN1217929C (zh)
AT (1) ATE298744T1 (zh)
AU (1) AU781398B2 (zh)
BR (1) BR0016223A (zh)
CA (1) CA2393518C (zh)
CZ (1) CZ294370B6 (zh)
DE (1) DE60021109T2 (zh)
DK (1) DK1237866T3 (zh)
EE (1) EE05219B1 (zh)
ES (1) ES2243332T3 (zh)
HK (1) HK1048998A1 (zh)
HR (1) HRP20020497B1 (zh)
HU (1) HU225194B1 (zh)
IL (2) IL149904A0 (zh)
ME (1) ME00182B (zh)
NO (1) NO322565B1 (zh)
PL (1) PL201809B1 (zh)
PT (1) PT1237866E (zh)
RS (1) RS50288B (zh)
RU (1) RU2261916C2 (zh)
SI (1) SI1237866T1 (zh)
SK (1) SK286776B6 (zh)
WO (1) WO2001042210A1 (zh)
ZA (1) ZA200204420B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、mi710−51f6物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質mi481−42f4−a及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンbおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンaおよびbとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンcおよびdとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
CA2393518C (en) 2009-01-20
RS50288B (sr) 2009-09-08
HUP0203593A2 (hu) 2003-02-28
KR20020063205A (ko) 2002-08-01
HRP20020497B1 (en) 2006-04-30
AU781398B2 (en) 2005-05-19
BR0016223A (pt) 2002-09-10
NO322565B1 (no) 2006-10-23
RU2002118116A (ru) 2004-02-27
SI1237866T1 (en) 2005-10-31
DE60021109D1 (de) 2005-08-04
CZ294370B6 (cs) 2004-12-15
EP1237866B1 (en) 2005-06-29
HRP20020497A2 (en) 2004-08-31
CZ20021891A3 (cs) 2002-08-14
NO20022654L (no) 2002-06-05
PL201809B1 (pl) 2009-05-29
KR100728514B1 (ko) 2007-06-15
EE200200280A (et) 2003-06-16
CN1217929C (zh) 2005-09-07
ATE298744T1 (de) 2005-07-15
ES2243332T3 (es) 2005-12-01
US6642391B2 (en) 2003-11-04
PT1237866E (pt) 2005-10-31
AU2001901A (en) 2001-06-18
YU13102A (sh) 2005-06-10
EE05219B1 (et) 2009-10-15
DE60021109T2 (de) 2006-05-04
JP2003516389A (ja) 2003-05-13
HU225194B1 (en) 2006-08-28
IL149904A0 (en) 2002-11-10
MEP28508A (en) 2010-10-10
NO20022654D0 (no) 2002-06-05
US20010018450A1 (en) 2001-08-30
SK286776B6 (sk) 2009-05-07
EP1237866A1 (en) 2002-09-11
PL355627A1 (en) 2004-05-04
EP1106604A1 (en) 2001-06-13
HUP0203593A3 (en) 2003-12-29
HK1048998A1 (en) 2003-04-25
DK1237866T3 (da) 2005-10-10
CA2393518A1 (en) 2001-06-14
JP4750993B2 (ja) 2011-08-17
WO2001042210A1 (en) 2001-06-14
RU2261916C2 (ru) 2005-10-10
IL149904A (en) 2007-10-31
ME00182B (me) 2010-10-10
CN1377341A (zh) 2002-10-30
SK7872002A3 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
AU679021B2 (en) N-heteroaryl-N'-phenylurea derivatives, their production and use
AU1025795A (en) Prolineamide derivatives
PL357909A1 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
AU635758B2 (en) Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
AU4022293A (en) 5-0-desosaminylerythronolide a derivative
EP0388956A3 (en) Phthalinide derivative, pharmaceutical composition and use
AU2722095A (en) Novel pyrrolocarbazoles
ES2062336T3 (es) Derivados de benzoxepina.
HU908256D0 (en) Process for the production of the derivatives of the bu-3608 antibiotic-complex
AU695521B2 (en) Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
ZA200204420B (en) Amycomycin, a process for its production and its use as a pharmaceutical.
GR3025607T3 (en) A novel antibiotic, Deoxymulundocandin, a process for its production and its use as medicament
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
DE69914880D1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
EP0955376A4 (en) ANTIBIOTIC TKR 459, PRODUCTION METHOD THEREOF AND MICROORGANISM
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
HRP970714B1 (en) Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use
GB8803426D0 (en) New compound wf 11605
AU2001278793A1 (en) Production process of l-phenylalanine derivatives by microorganisms